solidphase double-antibody elisa (Solid Phase Inc)
90
Structured Review
Solid Phase Inc
solidphase double-antibody elisa
Solidphase Double Antibody Elisa, supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solidphase+double-antibody+elisa/solidphase+double+antibody+elisa/pm12748424-38-21-20
Average 90 stars, based on 1 article reviews
Solidphase Double Antibody Elisa, supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solidphase+double-antibody+elisa/solidphase+double+antibody+elisa/pm12748424-38-21-20
Average 90 stars, based on 1 article reviews
solidphase double-antibody elisa - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
RIA Assay:Article Title: Abstract (Part 4 of 5) Article Snippet: course of the disease is essential because of the frequent development of systemic complications.. Several single and multifactorial prognostic factors investigated in acute pancreatitis have shown different specifi city and sensitivity for distinguishing between severe and mild forms of the diseases.. Aim. Article Title: A study on the activation peptide released from procarboxypeptidase B (CAPAP) and anionic trypsinogen in patients with acute abdominal disorders of non-pancreatic origin. Article Snippet: Background: The activation peptide released from procarboxypeptidase B, CAPAP, is a marker of the activation of pancreatic enzymes in acute pancreatitis while anionic trypsinogen (AT) levels in urine relate to leakage of unactivated proenzymes.. Data on these markers in patients suffering from severe acute abdominal disorders of nonpancreatic origin are lacking.. Purpose: To examine levels of CAPAP and AT in serum and urine from patients with severe acute abdominal disorders of non-pancreatic origin in order to better define the diagnostic specificity of these two markers in severe acute pancreatitis in relation to other acute intra-abdominal disorders. Enzyme-linked Immunosorbent Assay:Article Title: Abstract (Part 4 of 5) Article Snippet: course of the disease is essential because of the frequent development of systemic complications.. Several single and multifactorial prognostic factors investigated in acute pancreatitis have shown different specifi city and sensitivity for distinguishing between severe and mild forms of the diseases.. Aim. Article Title: A study on the activation peptide released from procarboxypeptidase B (CAPAP) and anionic trypsinogen in patients with acute abdominal disorders of non-pancreatic origin. Article Snippet: Background: The activation peptide released from procarboxypeptidase B, CAPAP, is a marker of the activation of pancreatic enzymes in acute pancreatitis while anionic trypsinogen (AT) levels in urine relate to leakage of unactivated proenzymes.. Data on these markers in patients suffering from severe acute abdominal disorders of nonpancreatic origin are lacking.. Purpose: To examine levels of CAPAP and AT in serum and urine from patients with severe acute abdominal disorders of non-pancreatic origin in order to better define the diagnostic specificity of these two markers in severe acute pancreatitis in relation to other acute intra-abdominal disorders. |